Matthias Peipp | Head - Division of Antibody-Based Immunotherapy
UKSH - University Hospital Schleswig-Holstein

Matthias received his PhD at the chair of genetics at the Friedrich-Alexander-University (Erlangen- Nuremberg, Germany). In 2015 he was awarded an endowed professorship, the “Mildred-Scheel-Professorship for Experimental Antibody-Based Cancer Immunotherapy”. Matthias has a long-standing expertise in antibody engineering and effector mechanisms triggered by antibodies and antibody derivatives. In 2022 he became head of the newly formed Division of Antibody-Based Immunotherapy at the University Hospital Schleswigholstein in in Kiel (Germany). In 2024 he was appointed as full professor in Translational Leukemia Research. Besides his academic duties he acts as scientific advisor to several pharmaceutical companies.